These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8405096)

  • 1. Stress activation of mesocorticolimbic dopamine neurons: effects of a glycine/NMDA receptor antagonist.
    Morrow BA; Clark WA; Roth RH
    Eur J Pharmacol; 1993 Jul; 238(2-3):255-62. PubMed ID: 8405096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of FG 7142-induced increased dopamine utilization by the glycine/NMDA receptor antagonist (+)-HA 966.
    Horger BA; Elsworth JD; Roth RH
    J Neurochem; 1996 May; 66(5):1959-62. PubMed ID: 8780023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat.
    Goldstein LE; Rasmusson AM; Bunney BS; Roth RH
    J Neurosci; 1994 Aug; 14(8):4937-50. PubMed ID: 8046462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential actions of dizocilpine (MK-801) on the mesolimbic and mesocortical dopamine systems: role of neuronal activity.
    Mathé JM; Nomikos GG; Blakeman KH; Svensson TH
    Neuropharmacology; 1999 Jan; 38(1):121-8. PubMed ID: 10193903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local activation of metabotropic glutamate receptors inhibits the handling-induced increased release of dopamine in the nucleus accumbens but not that of dopamine or noradrenaline in the prefrontal cortex: comparison with inhibition of ionotropic receptors.
    Feenstra MG; Botterblom MH; van Uum JF
    J Neurochem; 1998 Mar; 70(3):1104-13. PubMed ID: 9489731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity.
    Del Arco A; Segovia G; Mora F
    Psychopharmacology (Berl); 2008 Dec; 201(3):325-38. PubMed ID: 18751970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats.
    Bubser M; Tzschentke T; Hauber W
    J Neural Transm Gen Sect; 1995; 101(1-3):115-26. PubMed ID: 8695042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.
    Bristow LJ; Hutson PH; Thorn L; Tricklebank MD
    Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell.
    King D; Zigmond MJ; Finlay JM
    Neuroscience; 1997 Mar; 77(1):141-53. PubMed ID: 9044382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locomotor activity induced by the non-competitive N-methyl-D-aspartate antagonist, MK-801: role of nucleus accumbens efferent pathways.
    De Leonibus E; Mele A; Oliverio A; Pert A
    Neuroscience; 2001; 104(1):105-16. PubMed ID: 11311535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (S)-(-)-HA-966, a gamma-hydroxybutyrate-like agent, prevents enhanced mesocorticolimbic dopamine metabolism and behavioral correlates of restraint stress, conditioned fear and cocaine sensitization.
    Morrow BA; Lee EJ; Taylor JR; Elsworth JD; Nye HE; Roth RH
    J Pharmacol Exp Ther; 1997 Nov; 283(2):712-21. PubMed ID: 9353390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-701,324, a glycine/NMDA receptor antagonist, blocks the increase of cortical dopamine metabolism by stress and DMCM.
    Hutson PH; Barton CL
    Eur J Pharmacol; 1997 May; 326(2-3):127-32. PubMed ID: 9196264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dizocilpine (MK-801) and tetrodotoxin influence accumbal dopamine release evoked by intrapallidal morphine.
    Anagnostakis Y; Kastellakis A; Spyraki C
    Eur Neuropsychopharmacol; 1998 Feb; 8(1):47-53. PubMed ID: 9452940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
    Umino A; Takahashi K; Nishikawa T
    Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of dopamine terminals in the medial prefrontal cortex increased the ratio of DOPAC to DA in tissue of the nucleus accumbens shell: role of stress.
    King D; Finlay JM
    Brain Res; 1997 Sep; 767(2):192-200. PubMed ID: 9367247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of ceruletide, a cholecystokinin analog, to the neurochemical effects of the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists, phencyclidine and MK-801, on regional dopaminergic neurons in the rat brain.
    Kuroki T; Tatebayashi Y; Ide K; Yonezawa Y; Tsutsumi T; Matsumoto T; Hirano M; Uchimura H
    Neuropeptides; 1992 Mar; 21(3):167-73. PubMed ID: 1385857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of glutamate neurotransmission and N-methyl-d-aspartate receptor in the activation of midbrain dopamine neurons by 5-HT1A receptor agonists: an electrophysiological study in the rat.
    Gronier B
    Neuroscience; 2008 Oct; 156(4):995-1004. PubMed ID: 18801415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine-induced Fos expression in the nucleus accumbens and the medial prefrontal cortex of the rat: role of nicotinic and NMDA receptors in the ventral tegmental area.
    Schilström B; De Villiers S; Malmerfelt A; Svensson TH; Nomikos GG
    Synapse; 2000 Jun; 36(4):314-21. PubMed ID: 10819909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
    Kosowski AR; Liljequist S
    J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex.
    Lecourtier L; Homayoun H; Tamagnan G; Moghaddam B
    Biol Psychiatry; 2007 Oct; 62(7):739-46. PubMed ID: 17511968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.